NICO Corporation
26 articles about NICO Corporation
-
Study Shows First-Ever Successful Deep-Brain Implant of Computer Chip in Living Animal
10/31/2023
A first study demonstrating successful deep-brain placement of a brain computer interface microchip into a living animal with no apparent neurological effects is now published from Julian E. Bailes, MD, a recognized leader in the field of neurosurgery and co-director of the NorthShore University HealthSystem.
-
NICO Infuses Additional $1M into Grant Program Following World's First Positive Trial for ICH
5/11/2023
Following the April 22 announcement of the world's first positive clinical trial for hemorrhagic stroke, trial sponsor NICO Corporation announced that it is infusing another $1 million into its Investigator Initiated Study Grant Program to support further scientific advancements in vascular, tumor, and oncology precision medicine using its novel neurosurgical technologies.
-
NICO Awards $40,000 Grant to Study Genetic & Biological Make-Up of Meningioma Brain Tumors
5/4/2023
NICO Corporation, an Indianapolis-based pioneer and leader in minimally invasive neurosurgery, has awarded a $40,000 grant to Daniel Prevedello, MD, vice chair for Academic Affairs and director of Skull Base and Pituitary Surgery Programs at the Ohio State University Comprehensive Cancer Center.
-
NICO Corporation Among Early Companies to Successfully Transition to New EU MDR Requirements for Class III Medical Devices
4/27/2023
NICO Corporation, an Indianapolis-based pioneer and leader in minimally invasive neurosurgery, announced it is among early companies to successfully complete transition to the new European Union Medical Device Regulation.
-
NICO Corporation Announces World's First Positive Surgical Trial for the Deadliest Type of Stroke
4/22/2023
NICO Corporation announced initial positive results from the completed ENRICH trial at the 2023 American Association of Neurological Surgeons annual scientific meeting.
-
NICO Awards $180,000 Grant to Study GBM Progression Using Novel Longitudinal Serial Sampling in Translational Research
4/19/2023
NICO Corporation has awarded Arabinda Das, PhD, neuroscientist and neuro-oncology assistant professor at the Medical University of South Carolina, a $180,000 Investigator Initiated Study grant supporting the development of a new glioblastoma patient-derived xenograft model.
-
NICO Corporation Receives 2023 Pioneer in Technology Development Award
2/23/2023
NICO Corporation is honored to receive the 2023 Pioneer in Technology Development Award from the Society of Brain Mapping and Therapeutics, a biomedical association founded in 2004 to break boundaries in the areas of brain mapping and intra-operative surgical planning and support trailblazers in science and pioneers in neurotechnology.
-
First Adaptive Hemorrhagic Stroke Trial Completes Enrollment
10/6/2022
NICO Corporation announced that enrollment is now complete for the ENRICH randomized controlled trial.
-
NICO and Elite Medical "Dream Team" Form Oncology Tissue Advisory Board
9/8/2022
Surgeons, oncologists, and researchers all agree: When it comes to understanding complex and deadly brain tumors, tissue is the issue.
-
Neurosurgery Medical Device Maker, NICO Corporation, Expands Globally with International Training Course During World Stroke Meeting in Spain
6/3/2019
Indianapolis-based neurosurgical medical device maker NICO Corporation continued its international expansion in the European Union by holding its inaugural 2-day international course in Granada, Spain during the World Intracranial Hemorrhage Conference.
-
Viz.ai and NICO Corp. Announce Collaboration to Speed Patient Recruitment in the ENRICH Study
11/15/2018
NICO Corp. to install Viz Recruit, an AI based clinical trial enrollment platform at ENRICH sites to increase enrollment rates and reduce time to randomization in intracerebral hemorrhage (ICH).
-
NICO Awards First Investigator Initiated Study Grant to Mayo Clinic
11/14/2018
Grant supports physician-led evaluation of MIS technologies on ICH treatment
-
NICO Launches Investigator Initiated Study Program to Increase Scientific Data Supporting Minimally Invasive Neurosurgery
8/9/2018
Neurosurgical medical device maker NICO Corporation has launched an Investigator Initiated Study (IIS) Program offering financial support for prospective studies or the evaluation of retrospective data related to improved patient and economic outcomes using minimally invasive neurosurgery approaches.
-
NICO Corp. Adds to Strong Intellectual Property Portfolio of 200+ with New Patent Issued Around Revolutionary BrainPath Technology
7/17/2018
NICO Corporation has invested more than 10 years building, perfecting and protecting its diverse intellectual property (IP) portfolio encompassing technologies and methodologies around a better way of performing minimally disruptive brain surgery.
-
Global Healthcare Senior Executive Joins NICO Corp. Board of Directors
6/20/2018
Thomas M. Tefft, former Senior Vice President and President of Medtronic's $2 billion Neuromodulation business from 2009-2016, has joined the Board of Directors of Indianapolis neurosurgical medical device company, NICO Corporation
-
Accomplished CEO & Entrepreneur of the Year Joins NICO Corp. Board of Directors
6/6/2018
Eric B. Timko has joined the Board of Directors of Indianapolis neurosurgical medical device company, NICO Corporation.
-
Early Intervention of Hemorrhagic Stroke Trial Reaches 100 Patients
5/31/2018
More than 100 subjects are now enrolled in the ENRICH randomized controlled trial designed to compare the outcomes between early surgical intervention of clot removal using the minimally disruptive BrainPath® Approach (NICO Corporation) and the "watch and see" medical management standard of care.
-
Former Neurosurgery Chairman of Henry Ford Health System, Dr. Mark Rosenblum, Joins NICO Corporation Board of Directors
5/29/2018
Highly regarded neurosurgeon, Mark Rosenblum, MD, has joined the Board of Directors of Indianapolis-based medical device company, NICO Corporation.
-
NICO Continues to Innovate with Smallest Trans-Sulcal Brain Access Tool in the World
5/1/2018
NICO Corporation introduced today the 11 mm diameter BrainPath - the world's smallest trans-sulcal access system for subcortical surgery.
-
NICO Corporation Appoints New VP of Sales
1/19/2018
NICO Corporation, today announced Tim Davis as the new VP of Sales.